AN OPEN-LABEL PHASE I/II STUDY OF RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR (R-METHUG-CSF) AND RECOMBINANT ERYTHROPOIETIN (RHUEPO) GIVEN SUBCUTANEOUSLY ALONG WITH ZIDOVUDINE (AZT) TO PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) OR SEVERE AIDS-RELATED COMPLEX (ARC):